INVESTINGAbbVie Gains Pre-Earnings on Analyst Nod, Coronavirus Drug DemandBy M. Corey GoldmanFeb 6, 2020 10:54 AM EST
PRESS RELEASESModerna To Report Fourth Quarter And Full Year 2019 Financial Results On Wednesday, February 26th, 2020By Business WireFeb 12, 2020 4:30 PM EST
PRESS RELEASESModerna Announces Pricing Of Public Offering Of Shares Of Common StockBy Business WireFeb 11, 2020 10:12 PM EST
PRESS RELEASESModerna Announces Progress In Prophylactic Vaccines Modality With CMV Vaccine Phase 2 Study Data Now Expected In Third Quarter 2020 And Expands Investment In This Core Modality With Three New Development CandidatesBy Business WireFeb 10, 2020 5:11 PM EST
PRESS RELEASESModerna Announces First Patient Enrolled In Phase 1/2 Study Of MRNA-3704 For Methylmalonic AcidemiaBy Business WireFeb 10, 2020 5:10 PM EST
PRESS RELEASESModerna Announces Proposed Public Offering Of Shares Of Common StockBy Business WireFeb 10, 2020 4:13 PM EST
INVESTINGAbbVie Gains Pre-Earnings on Analyst Nod, Coronavirus Drug DemandBy M. Corey GoldmanFeb 6, 2020 10:54 AM EST
INVESTINGGilead Falls Post-Earnings but China Wants to Patent Its Coronavirus DrugBy M. Corey GoldmanFeb 5, 2020 9:40 AM EST
PRESS RELEASESSandra Horning, M.D. To Join Moderna's Board Of DirectorsBy Business WireFeb 3, 2020 8:00 AM EST
PRESS RELEASESMelanie Ivarsson, Ph.D. Joins Moderna As Chief Development OfficerBy Business WireJan 30, 2020 8:00 AM EST
INVESTINGJohnson & Johnson Says It's Working on a Coronavirus VaccineBy Dan WeilJan 29, 2020 10:19 AM EST
JIM CRAMERViral Risk: Cramer's 'Mad Money' Recap (Monday 1/27/20)By Scott RuttJan 27, 2020 8:41 PM EST
HEALTHAbbVie HIV Drugs Being Tested as Possible Coronavirus AntidoteBy M. Corey GoldmanJan 27, 2020 11:44 AM EST
HEALTHMcDonald's Halts Operations in Five China Cities Due to Coronavirus OutbreakBy Rob DanielJan 24, 2020 10:11 AM EST
PRESS RELEASESModerna Announces Funding Award From CEPI To Accelerate Development Of Messenger RNA (mRNA) Vaccine Against Novel CoronavirusBy Business WireJan 23, 2020 9:15 AM EST
HEALTHModerna, National Institutes of Health Join to Develop Coronavirus VaccineBy Tony OwusuJan 22, 2020 10:42 AM EST
PRESS RELEASESModerna Announces Additional Positive Phase 1 Data From Cytomegalovirus (CMV) Vaccine (mRNA-1647) And First Participant Dosed In Phase 2 StudyBy Business WireJan 9, 2020 4:01 PM EST
JIM CRAMERModerna, six flags, chevron and more: 'mad money' lightning roundBy Scott RuttJun 5, 2019 8:22 PM EDT
